Managing  ||| S:0 E:9 ||| VBG
hyponatremia  ||| S:9 E:22 ||| NN
in  ||| S:22 E:25 ||| IN
patients  ||| S:25 E:34 ||| NNS
with  ||| S:34 E:39 ||| IN
syndrome  ||| S:39 E:48 ||| NN
of  ||| S:48 E:51 ||| IN
inappropriate  ||| S:51 E:65 ||| JJ
antidiuretic  ||| S:65 E:78 ||| JJ
hormone  ||| S:78 E:86 ||| NN
secretion  ||| S:86 E:96 ||| VBD
This  ||| S:96 E:101 ||| DT
review  ||| S:101 E:108 ||| NN
will  ||| S:108 E:113 ||| MD
address  ||| S:113 E:121 ||| VB
the  ||| S:121 E:125 ||| DT
management  ||| S:125 E:136 ||| NN
of  ||| S:136 E:139 ||| IN
hyponatremia  ||| S:139 E:152 ||| VBG
caused  ||| S:152 E:159 ||| VBN
by  ||| S:159 E:162 ||| IN
the  ||| S:162 E:166 ||| DT
syndrome  ||| S:166 E:175 ||| NN
of  ||| S:175 E:178 ||| IN
inappropriate  ||| S:178 E:192 ||| JJ
antidiuretic  ||| S:192 E:205 ||| JJ
hormone  ||| S:205 E:213 ||| NN
secretion  ||| S:213 E:223 ||| NNS
( ||| S:223 E:224 ||| -LRB-
SIADH ||| S:224 E:229 ||| NNP
)  ||| S:229 E:231 ||| -RRB-
in  ||| S:231 E:234 ||| IN
hospitalized  ||| S:234 E:247 ||| JJ
patients ||| S:247 E:255 ||| NNS
.  ||| S:255 E:257 ||| .
To  ||| S:257 E:260 ||| TO
do  ||| S:260 E:263 ||| VB
so  ||| S:263 E:266 ||| RB
requires  ||| S:266 E:275 ||| VBZ
an  ||| S:275 E:278 ||| DT
understanding  ||| S:278 E:292 ||| NN
of  ||| S:292 E:295 ||| IN
the  ||| S:295 E:299 ||| DT
pathogenesis  ||| S:299 E:312 ||| NN
and  ||| S:312 E:316 ||| CC
diagnosis  ||| S:316 E:326 ||| NN
of  ||| S:326 E:329 ||| IN
SIADH ||| S:329 E:334 ||| NNP
,  ||| S:334 E:336 ||| ,
as  ||| S:336 E:339 ||| RB
well  ||| S:339 E:344 ||| RB
as  ||| S:344 E:347 ||| RB
currently  ||| S:347 E:357 ||| RB
available  ||| S:357 E:367 ||| JJ
treatment  ||| S:367 E:377 ||| NN
options ||| S:377 E:384 ||| NNS
.  ||| S:384 E:386 ||| .
The  ||| S:386 E:390 ||| DT
review  ||| S:390 E:397 ||| NN
will  ||| S:397 E:402 ||| MD
be  ||| S:402 E:405 ||| VB
structured  ||| S:405 E:416 ||| VBN
as  ||| S:416 E:419 ||| IN
responses  ||| S:419 E:429 ||| NNS
to  ||| S:429 E:432 ||| TO
a  ||| S:432 E:434 ||| DT
series  ||| S:434 E:441 ||| NN
of  ||| S:441 E:444 ||| IN
questions ||| S:444 E:453 ||| NNS
,  ||| S:453 E:455 ||| ,
followed  ||| S:455 E:464 ||| VBN
by  ||| S:464 E:467 ||| IN
a  ||| S:467 E:469 ||| DT
presentation  ||| S:469 E:482 ||| NN
of  ||| S:482 E:485 ||| IN
an  ||| S:485 E:488 ||| DT
algorithm  ||| S:488 E:498 ||| NN
for  ||| S:498 E:502 ||| IN
determining  ||| S:502 E:514 ||| VBG
the  ||| S:514 E:518 ||| DT
most  ||| S:518 E:523 ||| RBS
appropriate  ||| S:523 E:535 ||| JJ
treatments  ||| S:535 E:546 ||| NNS
for  ||| S:546 E:550 ||| IN
individual  ||| S:550 E:561 ||| JJ
patients  ||| S:561 E:570 ||| NNS
with  ||| S:570 E:575 ||| IN
SIADH  ||| S:575 E:581 ||| NNP
based  ||| S:581 E:587 ||| VBN
on  ||| S:587 E:590 ||| IN
their  ||| S:590 E:596 ||| PRP$
presenting  ||| S:596 E:607 ||| JJ
symptoms ||| S:607 E:615 ||| NNS
.  ||| S:615 E:617 ||| .
